Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00726310 · ClinicalTrials.gov registry record
Evaluation Of Spinelink® Fixation In The Treatment Of Degenerative Spondylolisthesis And Spinal Instability
A clinical trial of Degenerative Disc Disease and Degenerative Spondylolisthesis, sponsored by Zimmer Biomet.
- Completed
- Registry status
- 202
- Enrollment target
- 2
- Study locations
NCT00726310 is a study of Degenerative Disc Disease and Degenerative Spondylolisthesis that has completed, run by Zimmer Biomet. The registered enrollment target is 202 participants, above the 164-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (23% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT00726310, a study of Degenerative Disc Disease and Degenerative Spondylolisthesis, has completed, sponsored by Zimmer Biomet.
- COMPLETED
- Registry status
- 202 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this open, multi-center study is to prospectively collect outcome data on patients who are having lumbar spinal fusion surgery with implantation of the SpineLink® system.
Conditions Studied
Interventions
- DEVICE SpineLink® , SpineLink® II
Study Locations (2)
California
- Alvarado Orthopedic Clinic - San Diego
Florida
- Rogozinski Orthopedic Clinic - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 202 participants |
| Start Date | 2000-05 |
| Est. Completion | 2009-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00726310
The ClinicalTrials.gov registry entry for NCT00726310 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 202 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 164-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (23% higher). The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Degenerative Disc Disease appearing as the primary indexed condition, and to 1 intervention - of which SpineLink® , SpineLink® II is the first listed.
NCT00726310 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Florida.
Frequently Asked Questions
What is clinical trial NCT00726310 about?
NCT00726310 is a clinical study titled "Evaluation Of Spinelink® Fixation In The Treatment Of Degenerative Spondylolisthesis And Spinal Instability". The purpose of this open, multi-center study is to prospectively collect outcome data on patients who are having lumbar spinal fusion surgery with implantation of the SpineLink® system.
What is the current status of trial NCT00726310?
This trial is currently completed. The enrollment target is 202 participants. The study started on 2000-05. Estimated completion is 2009-11.
What conditions does trial NCT00726310 study?
This clinical trial studies the following conditions: Degenerative Disc Disease, Degenerative Spondylolisthesis.
What interventions are being tested in trial NCT00726310?
The interventions under investigation include: SpineLink® , SpineLink® II (DEVICE).
Who is sponsoring clinical trial NCT00726310?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00726310 being conducted?
This trial has 2 study locations across California, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Degenerative Disc Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
OssDsign® Spine Registry Study ("Propel")
RECRUITING
-
A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease
RECRUITING · Phase 3
-
LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF)
RECRUITING · Phase 1
-
Investigation of DEXA-C Anterior Cervical Interbody System
RECRUITING · NA
-
Post Marketing Study of MagnetOs Easypack Putty Standalone Compared to Demineralized Bone Matrix or Fibers Mixed With Autograft in Patients Undergoing Posterolateral Lumbar Fusion
RECRUITING · NA
-
Trial for Treating Painful Degenerative Disc Disease
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.